Colorectal Cancer Clinical Trials in Philadelphia

Showing 161-180 of 259 trials

Life After Cancer: Behavioral Treatment Study to Improve Quality of Life

NCT00473941

The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.

Colorectal Cancer

Temple University193 participantsStarted Sep 2005

Philadelphia, Pennsylvania, United States

UNKNOWNPhase 2< 1 mile

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

NCT03457896

This is a phase II trial to examine the efficacy of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (all RAS/NRAS/BRAF/PIK3CA wild-type), metastatic colorectal cancer based on HER2 status (amplified, non-amplified \[wild-type\] or mutated). Patients must have confirmed quadruple wild-type (WT) genotype, via NSABP MPR-1 or from colonic biopsy or a metastatic biopsy taken prior to treatment, and known HER2 status.

Metastatic Colorectal Cancer

NSABP Foundation Inc35 participantsStarted May 2018

Anaheim, California, United States • Baldwin Park, California, United States • Bellflower, California, United States +45 more locations

Life After Cancer: Behavioral Treatment Study to Improve Quality of Life

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Colorectal Cancer Trials in Other Cities

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Feasibility Bowel Dysfunction Program After Low Anterior Resection

Plasma-based Colorectal Cancer Screening Research & Development

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Other Conditions in Philadelphia